We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JRVR icon
13301
CALL
James River Group Holdings
JRVR
$193M
$7.3K ﹤0.01%
400
-300
-43% -$5.97K
EXPR
13302
PUT
DELISTED
Express, Inc.
EXPR
$7.24K ﹤0.01%
610
-155
-20% -$2.25K
OLK
13303
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$7.2K ﹤0.01%
384
-9,156
-96% -$189K
LCTX icon
13304
CALL
Lineage Cell Therapeutics
LCTX
$271M
$7.19K ﹤0.01%
5,100
-18,200
-78% -$25.2K
VVOS icon
13305
CALL
Vivos Therapeutics
VVOS
$4.77M
$7.19K ﹤0.01%
564
-528
-48% -$5.17K
SANA icon
13306
PUT
Sana Biotechnology
SANA
$1.06B
$7.15K ﹤0.01%
1,200
-8,600
-88% -$49.6K
BVH
13307
PUT
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$7.13K ﹤0.01%
200
-300
-60% -$9.02K
LXFR icon
13308
PUT
Luxfer Holdings
LXFR
$457M
$7.12K ﹤0.01%
+500
New +$7.66K
VOR icon
13309
CALL
Vor Biopharma
VOR
$1.36B
$7.11K ﹤0.01%
115
-785
-87% -$71.7K
DMRA
13310
PUT
Damora Therapeutics
DMRA
$1.92B
$7.06K ﹤0.01%
112
+72
+180% +$3.92K
SPIR icon
13311
PUT
Spire Global
SPIR
$567M
$7.06K ﹤0.01%
1,713
-5,800
-77% -$30.9K
MCRI icon
13312
PUT
Monarch Casino & Resort
MCRI
$2.22B
$7.04K ﹤0.01%
100
-1,300
-93% -$90.7K
BZFD icon
13313
CALL
BuzzFeed
BZFD
$92.5M
$7.02K ﹤0.01%
3,475
-27,975
-89% -$75.5K
CRWS icon
13314
CALL
Crown Crafts
CRWS
$30.7M
$7.01K ﹤0.01%
1,400
+800
+133% +$4.26K
NTCO
13315
PUT
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$6.97K ﹤0.01%
1,000
-1,800
-64% -$9.78K
TECX
13316
CALL
Tectonic Therapeutic
TECX
$682M
$6.94K ﹤0.01%
608
KG
13317
PUT
Kestrel Group
KG
$61.7M
$6.93K ﹤0.01%
165
LRMR icon
13318
CALL
Larimar Therapeutics
LRMR
$453M
$6.89K ﹤0.01%
+2,200
New +$8.98K
LXP icon
13319
CALL
LXP Industrial Trust
LXP
$3.57B
$6.83K ﹤0.01%
140
-1,200
-90% -$59.3K
ISUN
13320
DELISTED
iSun, Inc. Common Stock
ISUN
$6.82K ﹤0.01%
17,057
-28,597
-63% -$17.2K
BGMS
13321
Bio Green Med Solution Inc
BGMS
$5.05M
$6.76K ﹤0.01%
3
+2
+200% +$4.46K
ORN icon
13322
PUT
Orion Group Holdings
ORN
$402M
$6.74K ﹤0.01%
2,400
+1,600
+200% +$4.08K
LNAI
13323
CALL
Lunai Bioworks
LNAI
$10.1M
$6.74K ﹤0.01%
+149
New +$11.4K
FPE icon
13324
First Trust Preferred Securities and Income ETF
FPE
$6.34B
$6.71K ﹤0.01%
420
-64,505
-99% -$1.03M
SCHO icon
13325
Schwab Short-Term US Treasury ETF
SCHO
$13B
$6.68K ﹤0.01%
278
-1,240
-82% -$30.1K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.